SCHEMBL19298

SCHEMBL19298

CC#CC1CN(S(=O)(=O)c2nccs2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1

nearest known ligand 0.66

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 14/20 0.66
GCK P35557 8/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12078139 1.00 GCKR (0.66) GCKRGCK
SCHEMBL20341 1.00 GCKR (0.66) GCKRGCK
SCHEMBL12089939 0.92 GCKR (0.67) GCKRGCK
SCHEMBL12089941 0.92 GCKR (0.67) GCKRGCK
SCHEMBL12090217 0.92 GCKR (0.67) GCKRGCK
SCHEMBL12093339 0.86 GCKR (0.69) GCKRGCK
SCHEMBL17638 0.86 GCKR (0.69) GCKRGCK
SCHEMBL12093528 0.84 GCKR (0.71) GCKRGCK
SCHEMBL20551 0.83 GCKR (0.68) GCKRGCK
SCHEMBL18454 0.83 GCKR (0.68) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431563-B2 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes AMGEN INC. (US) 2013-04-30 US disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed